Edding Genor (6998) Announces Name Change and Updated Stock Short Name

Bulletin Express02-03 19:25

Edding Genor Group Holdings Limited (formerly Genor Biopharma Holdings Limited, stock code 6998) has completed its official name change procedures. The certificate of incorporation on change of name, issued by the Registry of Companies in the Cayman Islands, confirms the transition from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited,” accompanied by a dual foreign name change from “嘉和生物藥業(開曼)控股有限公司” to “億騰嘉和醫藥集團有限公司” with effect from 9:00 a.m. on 30 December 2025 (Hong Kong time).

The Registrar of Companies in Hong Kong subsequently issued a certificate of registration of alteration of name, finalizing the new English and Chinese names under Part 16 of the Companies Ordinance (Cap. 622). Effective from 9:00 a.m. on 6 February 2026, the stock short name will change on the Main Board of The Stock Exchange of Hong Kong Limited from “GENOR” to “EDDING GENOR” in English and from “嘉和生物” to “億騰嘉和” in Chinese. The stock code remains 6998. The changes do not affect shareholders’ rights, and the company’s English and Chinese names remain “Edding Genor Group Holdings Limited” and “億騰嘉和醫藥集團有限公司” respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102764286?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 19:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102764286","market":"us","top_or_hot":-1,"title":"Edding Genor (6998) Announces Name Change and Updated Stock Short Name","media":"Bulletin Express","content":"<p>Edding Genor Group Holdings Limited (formerly Genor Biopharma Holdings Limited, stock code 6998) has completed its official name change procedures. The certificate of incorporation on change of name, issued by the Registry of Companies in the Cayman Islands, confirms the transition from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited,” accompanied by a dual foreign name change from “嘉和生物藥業(開曼)控股有限公司” to “億騰嘉和醫藥集團有限公司” with effect from 9:00 a.m. on 30 December 2025 (Hong Kong time).</p>\n<p>The Registrar of Companies in Hong Kong subsequently issued a certificate of registration of alteration of name, finalizing the new English and Chinese names under Part 16 of the Companies Ordinance (Cap. 622). Effective from 9:00 a.m. on 6 February 2026, the stock short name will change on the Main Board of The Stock Exchange of Hong Kong Limited from “GENOR” to “EDDING GENOR” in English and from “嘉和生物” to “億騰嘉和” in Chinese. The stock code remains 6998. The changes do not affect shareholders’ rights, and the company’s English and Chinese names remain “Edding Genor Group Holdings Limited” and “億騰嘉和醫藥集團有限公司” respectively.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Edding Genor (6998) Announces Name Change and Updated Stock Short Name</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEdding Genor (6998) Announces Name Change and Updated Stock Short Name\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-03 19:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Edding Genor Group Holdings Limited (formerly Genor Biopharma Holdings Limited, stock code 6998) has completed its official name change procedures. The certificate of incorporation on change of name, issued by the Registry of Companies in the Cayman Islands, confirms the transition from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited,” accompanied by a dual foreign name change from “嘉和生物藥業(開曼)控股有限公司” to “億騰嘉和醫藥集團有限公司” with effect from 9:00 a.m. on 30 December 2025 (Hong Kong time).</p>\n<p>The Registrar of Companies in Hong Kong subsequently issued a certificate of registration of alteration of name, finalizing the new English and Chinese names under Part 16 of the Companies Ordinance (Cap. 622). Effective from 9:00 a.m. on 6 February 2026, the stock short name will change on the Main Board of The Stock Exchange of Hong Kong Limited from “GENOR” to “EDDING GENOR” in English and from “嘉和生物” to “億騰嘉和” in Chinese. The stock code remains 6998. The changes do not affect shareholders’ rights, and the company’s English and Chinese names remain “Edding Genor Group Holdings Limited” and “億騰嘉和醫藥集團有限公司” respectively.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物","start_time":0,"source_url":"","article_id":"1102764286","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102764286","pubTimestamp":1770117954,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Edding Genor Group Holdings Limited (formerly Genor Biopharma Holdings Limited, stock code 6998) has completed its official name change procedures. The certificate of incorporation on change of name,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物"},"translate_title":"Edding Genor(6998)公布更名及更新股票简称","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"Edding Genor Group Holdings Limited (formerly Genor Biopharma Holdings Limited, stock code 6998) has completed its official name change procedures. The certificate of incorporation on change of name, issued by the Registry of Companies in the Cayman Islands, confirms the transition from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited,” accompanied by a dual foreign name change from “嘉和生物藥業(開曼)控股有限公司” to “億騰嘉和醫藥集團有限公司” with effect from 9:00 a.m. on 30 December 2025 (Hong Kong time).\nThe Registrar of Companies in Hong Kong subsequently issued a certificate of registration of alteration of name, finalizing the new English and Chinese names under Part 16 of the Companies Ordinance (Cap. 622). Effective from 9:00 a.m. on 6 February 2026, the stock short name will change on the Main Board of The Stock Exchange of Hong Kong Limited from “GENOR” to “EDDING GENOR” in English and from “嘉和生物” to “億騰嘉和” in Chinese. The stock code remains 6998. The changes do not affect shareholders’ rights, and the company’s English and Chinese names remain “Edding Genor Group Holdings Limited” and “億騰嘉和醫藥集團有限公司” respectively.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102764286","isCrawlerRequest":true}